265 related articles for article (PubMed ID: 9058215)
1. Heparin detection by the activated coagulation time: a comparison of the sensitivity of coagulation tests and heparin assays.
Murray DJ; Brosnahan WJ; Pennell B; Kapalanski D; Weiler JM; Olson J
J Cardiothorac Vasc Anesth; 1997 Feb; 11(1):24-8. PubMed ID: 9058215
[TBL] [Abstract][Full Text] [Related]
2. Correlations between activated clotting time values and heparin concentration measurements in young infants undergoing cardiopulmonary bypass.
Guzzetta NA; Monitz HG; Fernandez JD; Fazlollah TM; Knezevic A; Miller BE
Anesth Analg; 2010 Jul; 111(1):173-9. PubMed ID: 20519414
[TBL] [Abstract][Full Text] [Related]
3. Heparinase thromboelastography compared with activated coagulation time for protamine titration after cardiopulmonary bypass.
Levin AI; Heine AM; Coetzee JF; Coetzee A
J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):224-9. PubMed ID: 24461364
[TBL] [Abstract][Full Text] [Related]
4. Thromboprophylaxis With Heparin During Orthotopic Liver Transplantation: Comparison of Hepcon HMS Plus and Anti-Xa Assays for Low-Range Heparin.
Nicolau-Raducu R; Occhipinti E; Marshall T; Koveleskie J; Ganier D; Evans B; Daly W; Fish B; Cohen AJ; Reichman TW; Bruce D; Bohorquez H; Seal J; Ahmed E; Carmody I; Loss G; Rayburn J; Nossaman B
J Cardiothorac Vasc Anesth; 2017 Apr; 31(2):575-581. PubMed ID: 27745797
[TBL] [Abstract][Full Text] [Related]
5. Elevated activated partial thromboplastin time does not correlate with heparin rebound following cardiac surgery.
Taneja R; Marwaha G; Sinha P; Quantz M; Stitt L; Gao R; Subramanian S; Schaus M; Keeney M; Chin-Yee I; Murkin J
Can J Anaesth; 2009 Jul; 56(7):489-96. PubMed ID: 19408066
[TBL] [Abstract][Full Text] [Related]
6. Reappearance of circulating heparin in whole blood heparin concentration-based management does not correlate with postoperative bleeding after cardiac surgery.
Ichikawa J; Kodaka M; Nishiyama K; Hirasaki Y; Ozaki M; Komori M
J Cardiothorac Vasc Anesth; 2014 Aug; 28(4):1003-7. PubMed ID: 24508375
[TBL] [Abstract][Full Text] [Related]
7. Monitoring incomplete heparin reversal and heparin rebound after cardiac surgery.
Galeone A; Rotunno C; Guida P; Bisceglie A; Rubino G; Schinosa Lde L; Paparella D
J Cardiothorac Vasc Anesth; 2013 Oct; 27(5):853-8. PubMed ID: 23627997
[TBL] [Abstract][Full Text] [Related]
8. Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery.
Yamamoto T; Wolf HG; Sinzobahamvya N; Asfour B; Hraska V; Schindler E
Thorac Cardiovasc Surg; 2015 Aug; 63(5):397-403. PubMed ID: 26121380
[TBL] [Abstract][Full Text] [Related]
9. Measurement of heparin concentration in whole blood with the Hepcon/HMS device does not agree with laboratory determination of plasma heparin concentration using a chromogenic substrate for activated factor X.
Hardy JF; Bélisle S; Robitaille D; Perrault J; Roy M; Gagnon L
J Thorac Cardiovasc Surg; 1996 Jul; 112(1):154-61. PubMed ID: 8691862
[TBL] [Abstract][Full Text] [Related]
10. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
[TBL] [Abstract][Full Text] [Related]
11. Heparin monitoring during cardiac surgery. Part 1: Validation of whole-blood heparin concentration and activated clotting time.
Raymond PD; Ray MJ; Callen SN; Marsh NA
Perfusion; 2003 Sep; 18(5):269-76. PubMed ID: 14604242
[TBL] [Abstract][Full Text] [Related]
12. The activated coagulation time: suitability for monitoring heparin effect and neutralization during pediatric cardiac surgery.
Martindale SJ; Shayevitz JR; D'Errico C
J Cardiothorac Vasc Anesth; 1996 Jun; 10(4):458-63. PubMed ID: 8776637
[TBL] [Abstract][Full Text] [Related]
13. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
Vonk AB; Veerhoek D; van den Brom CE; van Barneveld LJ; Boer C
J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152
[TBL] [Abstract][Full Text] [Related]
14. Age-related differences in heparin sensitivity and heparin-protamine interactions in cardiac surgery patients.
D'Errico C; Shayevitz JR; Martindale SJ
J Cardiothorac Vasc Anesth; 1996 Jun; 10(4):451-7. PubMed ID: 8776636
[TBL] [Abstract][Full Text] [Related]
15. Correlation of ACT as measured with three commercially available devices with circulating heparin level during cardiac surgery.
Niles SD; Sutton RG; Ploessl J; Pennell B
J Extra Corpor Technol; 1995 Dec; 27(4):197-200. PubMed ID: 10172651
[TBL] [Abstract][Full Text] [Related]
16. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
[TBL] [Abstract][Full Text] [Related]
17. Heparin-protamine balance after neonatal cardiopulmonary bypass surgery.
Peterson JA; Maroney SA; Zwifelhofer W; Wood JP; Yan K; Bercovitz RS; Woods RK; Mast AE
J Thromb Haemost; 2018 Oct; 16(10):1973-1983. PubMed ID: 30016577
[TBL] [Abstract][Full Text] [Related]
18. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
[TBL] [Abstract][Full Text] [Related]
19. The detection of changes in heparin activity in the rabbit: a comparison of anti-xa activity, thrombelastography, activated partial thromboplastin time, and activated coagulation time.
Nielsen VG
Anesth Analg; 2002 Dec; 95(6):1503-6, table of contents. PubMed ID: 12456408
[TBL] [Abstract][Full Text] [Related]
20. A novel thrombelastograph tissue factor/kaolin assay of activated clotting times for monitoring heparin anticoagulation during cardiopulmonary bypass.
Chavez JJ; Foley DE; Snider CC; Howell JC; Cohen E; Muenchen RA; Carroll RC
Anesth Analg; 2004 Nov; 99(5):1290-1294. PubMed ID: 15502019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
